The US Food and Drug Administration (FDA) approved the first-ever anti-depression nasal spray, Spravato. The pharmaceutical ...

Ketamine has been used as an anesthetic before surgeries for decades, but it can also be an option for those struggling with ...

In a Phase IIb trial, GH001 elicited significant drops in treatment-resistant depression. The news comes less than two weeks ...

Medicaid in Wisconsin has expanded to cover ketamine infusions as of Jan. 1, sparking conversations about the nuances in type ...

Each of the RSU grants vests ratably in equal installments on the first, second, and third anniversaries of the grant date, subject to the recipient's continued service with the Company through the ...

GH Research's inhaled psychedelic therapy GH001 has shown promise in a mid-stage trial in treatment-resistant depression (TRD ...

The recent acquisitions by pharmaceutical giants Johnson & Johnson and Bristol Myers Squibb, worth a combined $28billion, ...

It is now approved for adults with treatment-resistant depression (TRD) who have cycled through multiple treatments without relief. Spravato (esketamine) has been touted as a potential blockbuster ...

Dividend growth stocks offer a balance of stability and compounding returns, and here are three standout companies with ...

Within this Research Topic, five papers delve into alternative treatments for depression, investigating the effects and mechanisms of serotonergic psychedelics (like ayahuasca), oral esketamine, the ...

Jan. 30, 2025 — Women who go on to develop postpartum depression (PPD) may have characteristic levels of neuroactive steroids, molecules derived from the hormone progesterone, in their blood ...

Trusted resource of information on Anxiety & Depression that includes articles, news, videos, animations, quizzes, ...